Combining [Arene-Ru] with Azocarboxamide to Generate a Complex with Cytotoxic Properties

The Potent Oxidant Anticancer Activity of Organoiridium Catalysts

(2014) Zhe Liu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Synthesis, Characterization and Cytotoxicity of (η6-p-cymene)ruthenium(II) Complexes of α-Amino Acids

(2014) Folake A. Egbewande et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Exploring the Scope of Pyridyl- and Picolyl-Functionalized 1,2,3-Triazol-5-ylidenes in Bidentate Coordination to Ruthenium(II) Cymene Chloride Complexes

(2014) Aljoša Bolje et al.   ORGANOMETALLICS

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

(2014) Robert Trondl et al.   Chemical Science

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity

(2014) Zenita Adhireksan et al.   Nature Communications

The Contrasting Activity of Iodido versus Chlorido Ruthenium and Osmium Arene Azo- and Imino-pyridine Anticancer Complexes: Control of Cell Selectivity, Cross-Resistance, p53 Dependence, and Apoptosis Pathway

(2013) Isolda Romero-Canelón et al.   JOURNAL OF MEDICINAL CHEMISTRY

Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications

(2013) Alexey A. Nazarov et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Designing organometallic compounds for catalysis and therapy

(2012) Anna Louisa Noffke et al.   CHEMICAL COMMUNICATIONS

Recent advances on the chemistry of transition metal complexes of 2-(arylazo)pyridines and its arylamino derivatives

(2012) Subhas Samanta et al.   DALTON TRANSACTIONS

Competition between glutathione and DNA oligonucleotides for ruthenium(ii) arene anticancer complexes

(2012) Fuyi Wang et al.   DALTON TRANSACTIONS

Anticancer activity of tetracationic arene ruthenium metalla-cycles

(2011) Nicolas P. E. Barry et al.   DALTON TRANSACTIONS

Targeted and multifunctional arene ruthenium chemotherapeutics

(2011) Gregory S. Smith et al.   DALTON TRANSACTIONS

Manifestations of Noninnocent Ligand Behavior

(2011) Wolfgang Kaim   INORGANIC CHEMISTRY

Template-Directed Synthesis of Hexanuclear Arene Ruthenium Complexes with Trigonal-Prismatic Architecture Based on 2,4,6-Tris(3-pyridyl)triazine Ligands

(2011) Julien Freudenreich et al.   ORGANOMETALLICS

Ruthenium-based chemotherapeutics: are they ready for prime time?

(2010) Emmanuel S. Antonarakis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

(2010) Anamaria Brozovic et al.   CRITICAL REVIEWS IN TOXICOLOGY

Anticancer activity of opened arene ruthenium metalla-assemblies

(2010) Nicolas P. E. Barry et al.   DALTON TRANSACTIONS

Reactive oxygen species, cellular redox systems, and apoptosis

(2010) Magdalena L. Circu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY

Areneruthenium complexes as anticancer agents

(2009) Georg Süss-Fink   DALTON TRANSACTIONS

Designing the Host-Guest Properties of Tetranuclear Arene Ruthenium Metalla-Rectangles to Accommodate a Pyrene Molecule

(2009) Nicolas P. E. Barry et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY

Catalytic organometallic anticancer complexes

(2008) S. J. Dougan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA